Antibiotics before age 2 increases risk for childhood obesity

March 22, 2016

While early antibiotic use has been associated with a number of rare long-term health consequences, new research links antibiotics to one of the most important and growing public health problems worldwide—obesity. A study published online in Gastroenterology, the official journal of the American Gastroenterological Association, found that administration of three or more courses of antibiotics before children reach an age of 2 years is associated with an increased risk of early childhood obesity.

"Antibiotics have been used to promote weight gain in livestock for several decades, and our research confirms that have the same effect in humans," said Frank Irving Scott, MD, MSCE, assistant professor of medicine at University of Colorado Anschutz Medical Campus, Aurora, and adjunct scholar, Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania, Philadelphia. "Our results do not imply that antibiotics should not be used when necessary, but rather encourage both physicians and parents to think twice about in infants in the absence of well-established indications."

The researchers performed a large population-representative cohort study in the United Kingdom to assess the association between antibiotic exposure before age 2 years and obesity at age 4 years. Children with antibiotic exposure had a 1.2 percent absolute and 25 percent relative increase in the risk of early childhood obesity. Risk is strongest when considering repeat exposures to antibiotics, particularly with three or more courses.

"Our work supports the theory that antibiotics may progressively alter the composition and function of the , thereby predisposing children to obesity as is seen in livestock and animal models," added Dr. Scott.

Antibiotics are prescribed during an estimated 49 million pediatric outpatient visits per year in the U.S. A large portion of these prescriptions (more than 10 million annually) are written for children without clear indication, despite increased awareness of the societal risks of antibiotic resistance, as well as other tangible risks, including dermatologic, allergic and infectious complications; inflammatory bowel disease; and autoimmune conditions.

Further research is required to assess whether these findings remain into adolescence and young adulthood, as well as to determine if early antibiotic usage leads to later-onset obesity. Research should also examine whether specific classes of antibiotics are more strongly associated with subsequent obesity.

The American Gastroenterological Association, through its Center for Gut Microbiome Research and Education, will continue to promote and share research related to antibiotics and , and their relation to the gut microbiome.

Explore further: Antibiotic exposure in infancy not associated with weight gain in childhood

More information: Frank I. Scott et al. Administration of Antibiotics to Children Before Age 2 Years Increases Risk for Childhood Obesity, Gastroenterology (2016). DOI: 10.1053/j.gastro.2016.03.006

Related Stories

Antibiotics influence childhood weight gain

December 2, 2015

Kids who take antibiotics during childhood gain weight faster than those who do not, according to Johns Hopkins Bloomberg School of Public Health research. Still, antibiotics are necessary in some cases.

Repeated use of antibiotics linked to diabetes risk

March 25, 2015

Repeated use of some types of antibiotics may put people at increased risk of developing type-2 diabetes by possibly altering their gut bacteria, according to a large observational study published today in the European Journal ...

Infant antibiotic use linked to adult diseases

May 13, 2015

A new study led by researchers at the University of Minnesota has found a three-way link among antibiotic use in infants, changes in the gut bacteria, and disease later in life. The imbalances in gut microbes, called dysbiosis, ...

Recommended for you

Researchers identify source of opioids' side effects

January 17, 2017

A commercially available drug may help drastically reduce two side effects of opioid painkillers—a growing tolerance and a paradoxical increased sensitivity to pain—without affecting the drugs' ability to reduce pain, ...

CVS generic competitor to EpiPen, sold at a 6th the price

January 12, 2017

CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to ...

Many misuse OTC sleep aids: survey

December 29, 2016

(HealthDay)—People struggling with insomnia often turn to non-prescription sleep remedies that may be habit-forming and are only intended for short-term use, according to a new Consumer Reports survey.

The pill won't kill your sexual desire, researchers say

December 15, 2016

Taking the pill doesn't lower your sexual desire, contrary to popular belief, according to research published in the Journal of Sexual Medicine. The authors of the research, from the University of Kentucky and Indiana University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.